XML 168 R2.htm IDEA: XBRL DOCUMENT v3.24.3
Pay vs Performance Disclosure
12 Months Ended
Jun. 30, 2024
USD ($)
$ / shares
Jun. 30, 2023
USD ($)
$ / shares
Jun. 30, 2022
USD ($)
$ / shares
Jun. 30, 2021
USD ($)
$ / shares
Pay vs Performance Disclosure        
Pay vs Performance Disclosure, Table
Summary Compensation
Table Total for PEO(1)
Compensation Actually
Paid to PEO(2)
Average
Summary
Compensation
Table Total for
Non-PEO NEOs
($)(1)
Average
Compensation
Actually Paid to
Non-PEO NEOs
($)(2)
Value of Initial Fixed $100
Investment Based On:
GAAP Net
Income/
(Loss)
($ millions)(4)(5)
Company
Selected
Measure:
Non-GAAP Diluted
EPS
($)(5)(6)
Year
Hollar
($)
Kaufmann
($)
Hollar
($)
Kaufmann
($)
Total
Shareholder
Return
($)(3)
Peer Group
Total
Shareholder
Return
($)(3)
202425,650,709 N/A28,304,007 N/A5,980,304 7,968,087 213 145 852 7.53 
202318,783,767 3,528,968 40,794,271 12,948,517 4,153,005 9,211,106 202 132 330 5.85 
2022N/A13,463,557 N/A3,175,014 4,110,560 2,918,363 109 127 (938)5.07 
2021N/A12,482,378 N/A9,686,761 3,715,505 4,121,383 115 125 611 5.57 
     
Company Selected Measure Name non-GAAP diluted EPS      
Named Executive Officers, Footnote The PEO for fiscal 2024 was Mr. Hollar. The PEOs for fiscal 2023 were Mr. Hollar and Michael C. Kaufmann. The PEO for fiscal 2022 and 2021 was Mr. Kaufmann. The Non-PEO NEOs for fiscal 2024 were Mses. Mayer and Weitzman and Messrs. Alt and Mason. The Non-PEO NEOs for fiscal 2023 were Mses. Patricia M. English, Mayer, and Weitzman and Messrs. Alt, Victor L. Crawford, and Mason. The Non-PEO NEOs for fiscal 2022 and 2021 were Ms. Mayer and Messrs. Crawford, Hollar, and Mason. Amounts set forth in the table for the PEO do not include Mr. Hollar’s compensation for years in which he did not serve as PEO. Where applicable, such amounts are included in the Non-PEO NEO amounts.      
Peer Group Issuers, Footnote Pursuant to the SEC rules, TSR measures the cumulative value of an initial investment of $100 on June 30, 2020, including the reinvestment of dividends, through and including the end of the applicable fiscal year for which TSR is calculated, or June 30, 2021, June 30, 2022, June 30, 2023, and June 30, 2024, respectively. As permitted by the SEC rules, the peer group referenced for purpose of the TSR comparison is the S&P 500 Health Care Index, which is the industry peer group used by the company for purposes of Item 201(e) of Regulation S-K. The separate peer group used by the Compensation Committee for purposes of determining compensation paid to our executive officers is described in the CD&A beginning on page 59.      
Adjustment To PEO Compensation, Footnote The following tables show the adjustments, each of which is prescribed by the SEC rules, made to calculate the CAP amounts from the Summary Compensation Table (“SCT”) amounts. The SCT amounts and the CAP amounts do not reflect the actual amount of compensation earned by or paid to our executives during the applicable years, but rather are amounts determined in accordance with Item 402 of Regulation S-K. Pursuant to the applicable rules, the amounts in the “Stock Awards” column from the SCT are subtracted from the SCT amounts and the values reflected in the table below are added or subtracted as applicable:
PEO Summary Compensation Table Total Compensation to Compensation Actually Paid Reconciliation
2024202320222021
PEO
Hollar
($)
Hollar
($)
Kaufmann
($)
Kaufmann
($)
Kaufmann
($)
SCT total compensation 25,650,709 18,783,767 3,528,968 13,463,557 12,482,378 
Adjustments for stock awards
Stock award values reported in SCT for the covered fiscal year (20,640,912)(14,828,888)(11,051,066)(10,197,832)
Fair value of stock awards granted in
the covered fiscal year — value at fiscal-year-end
20,398,094 29,849,423 10,213,707 10,748,666 
Change in fair value from end of prior fiscal year to vesting date for stock awards granted in prior fiscal years that vested during the covered fiscal year (329,335)460,516 2,703,218 (4,290,114)(4,389,981)
Change in fair value from end of prior fiscal year to end of the covered fiscal year for stock awards granted in prior fiscal years that were unvested at the end of the covered fiscal year2,379,497 5,649,120 5,791,292 (6,590,127)(482,158)
Change in dividends accrued 845,955 880,332 925,040 1,429,057 1,525,687 
Compensation actually paid (as calculated) 28,304,007 40,794,271 12,948,517 3,175,014 9,686,761 
     
Non-PEO NEO Average Total Compensation Amount $ 5,980,304 $ 4,153,005 $ 4,110,560 $ 3,715,505
Non-PEO NEO Average Compensation Actually Paid Amount $ 7,968,087 9,211,106 2,918,363 4,121,383
Adjustment to Non-PEO NEO Compensation Footnote The following tables show the adjustments, each of which is prescribed by the SEC rules, made to calculate the CAP amounts from the Summary Compensation Table (“SCT”) amounts. The SCT amounts and the CAP amounts do not reflect the actual amount of compensation earned by or paid to our executives during the applicable years, but rather are amounts determined in accordance with Item 402 of Regulation S-K. Pursuant to the applicable rules, the amounts in the “Stock Awards” column from the SCT are subtracted from the SCT amounts and the values reflected in the table below are added or subtracted as applicable:
Average Non-PEO NEO Summary Compensation Table Total Compensation to Average Compensation Actually Paid Reconciliation    
2024
($)*
2023
($)*
2022
($)*
2021
($)*
SCT total compensation 5,980,304 4,153,005 4,110,560 3,715,505 
Adjustments for stock awards
Stock award values reported in SCT for the covered fiscal year (4,370,314)(2,764,459)(3,137,498)(2,447,474)
Fair value of stock awards granted in the covered fiscal year — value at fiscal-year-end 5,630,751 4,439,800 2,948,596 2,579,674 
Change in fair value from end of prior fiscal year to vesting date for stock awards granted in prior fiscal years that vested during the covered fiscal year (105,237)464,885 (138,220)25,940 
Change in fair value from end of prior fiscal year to end of the covered fiscal year for stock awards granted in prior fiscal years that were unvested at the end of the covered fiscal year567,703 2,636,182 (1,185,583)(30,365)
Change in dividends accrued 264,879 281,692 320,508 278,103 
Compensation actually paid (as calculated)7,968,087 9,211,106 2,918,363 4,121,383 
*    Amounts presented are averages for the entire group of Non-PEO NEOs in each respective year.
     
Compensation Actually Paid vs. Total Shareholder Return
Compensation Actually Paid vs. Company and Total Shareholder Return
03_432963-1_bar_capvstsr.jpg
04_432963-1_gfx_legend_compactpaidtoHollar.jpg
Compensation Actually Paid to Hollar
02_432963-1_bar-legend_dg.ai.jpg
Compensation Actually Paid to Kaufmann
02_432963-1_bar-legend_lg.ai.jpg
Average Compensation Actually Paid to Non-PEO NEOs
04_432963-1_gfx_legend_linecardinalhealthtsr.jpg
Cardinal Health TSR
04_432963-1_gfx_legend_lines&p500health.jpg
S&P 500 Health Care Index TSR
     
Compensation Actually Paid vs. Net Income
Compensation Actually Paid vs. Net Income
03_432963-1_bar_PVP-netincome.jpg
04_432963-1_gfx_legend_compactpaidtoHollar.jpg
Compensation Actually Paid to Hollar
02_432963-1_bar-legend_dg.ai.jpg
Compensation Actually Paid to Kaufmann
02_432963-1_bar-legend_lg.ai.jpg
Average Compensation Actually Paid to Non-PEO NEOs
04_432963-1_gfx_legend_linecardinalhealthtsr.jpg
GAAP Net Income/(Loss)
     
Compensation Actually Paid vs. Company Selected Measure
Compensation Actually Paid vs. Non-GAAP Diluted EPS
03_432963-1_bar_capvsnon-gaap.jpg
04_432963-1_gfx_legend_compactpaidtoHollar.jpg
Compensation Actually Paid to Hollar
02_432963-1_bar-legend_dg.ai.jpg
Compensation Actually Paid to Kaufmann
02_432963-1_bar-legend_lg.ai.jpg
Average Compensation Actually Paid to Non-PEO NEOs
04_432963-1_gfx_legend_linecardinalhealthtsr.jpg
Non-GAAP Diluted EPS
     
Total Shareholder Return Vs Peer Group
Compensation Actually Paid vs. Company and Total Shareholder Return
03_432963-1_bar_capvstsr.jpg
04_432963-1_gfx_legend_compactpaidtoHollar.jpg
Compensation Actually Paid to Hollar
02_432963-1_bar-legend_dg.ai.jpg
Compensation Actually Paid to Kaufmann
02_432963-1_bar-legend_lg.ai.jpg
Average Compensation Actually Paid to Non-PEO NEOs
04_432963-1_gfx_legend_linecardinalhealthtsr.jpg
Cardinal Health TSR
04_432963-1_gfx_legend_lines&p500health.jpg
S&P 500 Health Care Index TSR
     
Tabular List, Table
Non-GAAP diluted EPS
Non-GAAP operating earnings
Operating cash flow
Annual dividend yield
     
Total Shareholder Return Amount $ 213 202 109 115
Peer Group Total Shareholder Return Amount 145 132 127 125
Net Income (Loss) $ 852,000,000 $ 330,000,000 $ (938,000,000) $ 611,000,000
Company Selected Measure Amount | $ / shares 7.53 5.85 5.07 5.57
Additional 402(v) Disclosure Represents the amounts of GAAP net earnings/(loss) attributable to Cardinal Health, Inc.The fiscal 2022 and 2023 amounts were revised from those reported in last year’s proxy statement as discussed on page 61.The primary financial metric for our PSU program is adjusted non-GAAP diluted EPS, which is defined on page 68. See Annex A for a reconciliation to the comparable financial measure prepared in accordance with GAAP and the reasons why we use non-GAAP financial measures.      
Measure:: 1        
Pay vs Performance Disclosure        
Name Non-GAAP diluted EPS      
Measure:: 2        
Pay vs Performance Disclosure        
Name Non-GAAP operating earnings      
Measure:: 3        
Pay vs Performance Disclosure        
Name Operating cash flow      
Measure:: 4        
Pay vs Performance Disclosure        
Name Annual dividend yield      
Hollar [Member]        
Pay vs Performance Disclosure        
PEO Total Compensation Amount $ 25,650,709 $ 18,783,767    
PEO Actually Paid Compensation Amount 28,304,007 40,794,271    
Kaufmann [Member]        
Pay vs Performance Disclosure        
PEO Total Compensation Amount   3,528,968 $ 13,463,557 $ 12,482,378
PEO Actually Paid Compensation Amount   12,948,517 3,175,014 9,686,761
PEO | Hollar [Member] | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount (20,640,912) (14,828,888)    
PEO | Hollar [Member] | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 20,398,094 29,849,423    
PEO | Hollar [Member] | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 2,379,497 5,649,120    
PEO | Hollar [Member] | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount (329,335) 460,516    
PEO | Hollar [Member] | Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 845,955 880,332    
PEO | Kaufmann [Member] | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount   0 (11,051,066) (10,197,832)
PEO | Kaufmann [Member] | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount   0 10,213,707 10,748,666
PEO | Kaufmann [Member] | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount   5,791,292 (6,590,127) (482,158)
PEO | Kaufmann [Member] | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount   2,703,218 (4,290,114) (4,389,981)
PEO | Kaufmann [Member] | Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount   925,040 1,429,057 1,525,687
Non-PEO NEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount (4,370,314) (2,764,459) (3,137,498) (2,447,474)
Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 5,630,751 4,439,800 2,948,596 2,579,674
Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 567,703 2,636,182 (1,185,583) (30,365)
Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount (105,237) 464,885 (138,220) 25,940
Non-PEO NEO | Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount $ 264,879 $ 281,692 $ 320,508 $ 278,103